drugset / Trial / NCT01791894

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

NCT01791894

NaSingle-groupOpen-labelBasic science

Summary

This pilot clinical trial studies arsenic trioxide in treating patients with basal cell carcinoma. Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stop them from dividing

Timeline

Start
2013-04
Primary completion
2013-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule Intravenous